Tata Chemicals Past Earnings Performance
Past criteria checks 0/6
Tata Chemicals has been growing earnings at an average annual rate of 5.7%, while the Chemicals industry saw earnings growing at 14.7% annually. Revenues have been growing at an average rate of 10.9% per year.
Key information
5.7%
Earnings growth rate
5.7%
EPS growth rate
| Chemicals Industry Growth | 17.7% |
| Revenue growth rate | 10.9% |
| Return on equity | -0.8% |
| Net Margin | -2.3% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Unpleasant Surprises Could Be In Store For Tata Chemicals Limited's (NSE:TATACHEM) Shares
Dec 01
Tata Chemicals (NSE:TATACHEM) Will Be Hoping To Turn Its Returns On Capital Around
Oct 14Is Tata Chemicals (NSE:TATACHEM) Using Too Much Debt?
Sep 18What Tata Chemicals Limited's (NSE:TATACHEM) P/S Is Not Telling You
Jul 12Increases to CEO Compensation Might Be Put On Hold For Now at Tata Chemicals Limited (NSE:TATACHEM)
Jun 20Tata Chemicals (NSE:TATACHEM) Will Pay A Smaller Dividend Than Last Year
Jun 05Tata Chemicals' (NSE:TATACHEM) Dividend Will Be Reduced To ₹15.00
May 22Some May Be Optimistic About Tata Chemicals' (NSE:TATACHEM) Earnings
May 07Should You Investigate Tata Chemicals Limited (NSE:TATACHEM) At ₹1,102?
Apr 16Improved Earnings Required Before Tata Chemicals Limited (NSE:TATACHEM) Stock's 33% Jump Looks Justified
Mar 08Tata Chemicals Limited Just Missed EPS By 31%: Here's What Analysts Think Will Happen Next
Feb 08Here's Why Tata Chemicals (NSE:TATACHEM) Can Manage Its Debt Responsibly
Jan 19Earnings Working Against Tata Chemicals Limited's (NSE:TATACHEM) Share Price
Dec 27Here's Why Tata Chemicals (NSE:TATACHEM) Can Manage Its Debt Responsibly
Sep 29Is Tata Chemicals Limited (NSE:TATACHEM) Potentially Undervalued?
Sep 08Tata Chemicals (NSE:TATACHEM) Is Increasing Its Dividend To ₹17.50
Jun 02Tata Chemicals (NSE:TATACHEM) Is Increasing Its Dividend To ₹17.50
May 19What Is Tata Chemicals Limited's (NSE:TATACHEM) Share Price Doing?
May 05At ₹955, Is Tata Chemicals Limited (NSE:TATACHEM) Worth Looking At Closely?
Jan 31Is Tata Chemicals (NSE:TATACHEM) A Risky Investment?
Dec 26Is Now The Time To Look At Buying Tata Chemicals Limited (NSE:TATACHEM)?
Sep 20We Think Tata Chemicals (NSE:TATACHEM) Can Stay On Top Of Its Debt
Aug 31Tata Chemicals' (NSE:TATACHEM) Shareholders Will Receive A Bigger Dividend Than Last Year
Jun 10Tata Chemicals (NSE:TATACHEM) Is Increasing Its Dividend To ₹12.50
May 17Tata Chemicals' (NSE:TATACHEM) Upcoming Dividend Will Be Larger Than Last Year's
May 03Tata Chemicals (NSE:TATACHEM) Has A Pretty Healthy Balance Sheet
Mar 03Is Tata Chemicals Limited (NSE:TATACHEM) Worth ₹915 Based On Its Intrinsic Value?
Feb 12Why Tata Chemicals Limited (NSE:TATACHEM) Could Be Worth Watching
Jan 26We Think Tata Chemicals (NSE:TATACHEM) Can Stay On Top Of Its Debt
Nov 23A Look At The Intrinsic Value Of Tata Chemicals Limited (NSE:TATACHEM)
Nov 04Is It Too Late To Consider Buying Tata Chemicals Limited (NSE:TATACHEM)?
Oct 18Is Tata Chemicals (NSE:TATACHEM) A Risky Investment?
Aug 03At ₹781, Is It Time To Put Tata Chemicals Limited (NSE:TATACHEM) On Your Watch List?
Jul 16Most Shareholders Will Probably Agree With Tata Chemicals Limited's (NSE:TATACHEM) CEO Compensation
Jun 25Is Tata Chemicals (NSE:TATACHEM) Using Too Much Debt?
Mar 24Tata Chemicals Limited's (NSE:TATACHEM) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Mar 08Revenue & Expenses Breakdown
How Tata Chemicals makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 149,930 | -3,400 | 46,610 | 0 |
| 30 Jun 24 | 149,920 | -1,060 | 44,480 | 0 |
| 31 Mar 24 | 154,210 | 2,820 | 42,910 | 0 |
| 31 Dec 23 | 163,530 | 18,200 | 42,210 | 0 |
| 30 Sep 23 | 167,710 | 20,600 | 41,810 | 0 |
| 30 Jun 23 | 170,120 | 22,650 | 41,290 | 0 |
| 31 Mar 23 | 167,890 | 23,350 | 40,630 | 0 |
| 31 Dec 22 | 158,631 | 20,866 | 20,647 | 0 |
| 30 Sep 22 | 148,561 | 19,896 | 19,117 | 0 |
| 30 Jun 22 | 136,391 | 15,576 | 17,997 | 0 |
| 31 Mar 22 | 126,220 | 12,530 | 34,840 | 0 |
| 31 Dec 21 | 117,777 | 8,014 | 18,914 | 0 |
| 30 Sep 21 | 112,422 | 6,613 | 17,880 | 0 |
| 30 Jun 21 | 108,289 | 5,311 | 16,823 | 0 |
| 31 Mar 21 | 101,998 | 2,564 | 15,333 | 0 |
| 31 Dec 20 | 99,417 | 4,293 | 14,091 | 0 |
| 30 Sep 20 | 99,590 | 4,355 | 14,130 | 0 |
| 30 Jun 20 | 101,209 | 6,620 | 14,356 | 0 |
| 31 Mar 20 | 103,568 | 8,066 | 15,259 | 0 |
| 31 Dec 19 | 114,887 | 11,995 | 16,446 | 0 |
| 30 Sep 19 | 115,717 | 11,916 | 17,377 | 0 |
| 30 Jun 19 | 114,489 | 11,585 | 17,413 | 0 |
| 31 Mar 19 | 103,367 | 9,319 | 15,569 | 0 |
| 31 Dec 18 | 110,920 | 10,695 | 18,764 | 0 |
| 30 Sep 18 | 108,328 | 13,955 | 17,275 | 0 |
| 30 Jun 18 | 105,871 | 13,319 | 16,376 | 0 |
| 31 Mar 18 | 102,697 | 12,906 | 15,876 | 0 |
| 31 Dec 17 | 128,262 | 12,110 | 17,132 | 0 |
| 30 Sep 17 | 123,813 | 8,930 | 16,902 | 0 |
| 30 Jun 17 | 122,988 | 7,999 | 16,641 | 0 |
| 31 Mar 17 | 103,461 | 8,796 | 16,206 | 0 |
| 31 Dec 16 | 163,372 | 8,854 | 19,158 | 0 |
| 30 Sep 16 | 168,402 | 8,292 | 19,146 | 0 |
| 30 Jun 16 | 173,604 | 8,388 | 19,293 | 0 |
| 31 Mar 16 | 148,729 | 6,964 | 17,088 | 0 |
| 31 Dec 15 | 174,436 | 4,638 | 40,098 | 0 |
| 30 Sep 15 | 176,230 | 5,719 | 39,810 | 0 |
| 30 Jun 15 | 174,196 | 5,740 | 39,092 | 0 |
| 31 Mar 15 | 172,045 | 5,965 | 17,485 | 0 |
| 31 Dec 14 | 170,708 | -5,551 | 37,425 | 0 |
| 30 Sep 14 | 169,026 | -8,091 | 37,258 | 0 |
| 30 Jun 14 | 164,427 | -9,317 | 37,058 | 0 |
| 31 Mar 14 | 158,854 | -10,320 | 36,386 | 0 |
Quality Earnings: TATACHEM is currently unprofitable.
Growing Profit Margin: TATACHEM is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: TATACHEM is unprofitable, but has reduced losses over the past 5 years at a rate of 5.7% per year.
Accelerating Growth: Unable to compare TATACHEM's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: TATACHEM is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (8.8%).
Return on Equity
High ROE: TATACHEM has a negative Return on Equity (-0.79%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/02 05:16 |
| End of Day Share Price | 2025/01/02 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Tata Chemicals Limited is covered by 30 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Mukesh Saraf | Avendus Spark |
| Ankur Periwal | Axis Capital Limited |
| Ayyathurai Rajkumar | Batlivala & Karani Securities India Pvt. Ltd. |